跳轉至內容
Merck
全部照片(3)

文件

B8686

Sigma-Aldrich

(+)-N-苄基尼凡诺

≥98% (HPLC), powder, CYP2C19 inhibitor

同義詞:

(5S)-5-乙基-5-苯基-3-(苯甲基)-2,4-咪唑烷二酮, 5-乙基-5-苯基-3-(苯甲基)乙内酰脲

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C18H18N2O2
CAS號碼:
分子量::
294.35
MDL號碼:
分類程式碼代碼:
12161501
PubChem物質ID:
NACRES:
NA.77

product name

(+)-N-苄基尼凡诺, ≥98% (HPLC), powder

化驗

≥98% (HPLC)

形狀

powder

溶解度

DMSO: >20 mg/mL
H2O: insoluble

儲存溫度

2-8°C

SMILES 字串

CC[C@]1(NC(=O)N(Cc2ccccc2)C1=O)c3ccccc3

InChI

1S/C18H18N2O2/c1-2-18(15-11-7-4-8-12-15)16(21)20(17(22)19-18)13-14-9-5-3-6-10-14/h3-12H,2,13H2,1H3,(H,19,22)/t18-/m0/s1

InChI 密鑰

ZMZDHUHMXXALFX-SFHVURJKSA-N

相關類別

應用

(+)-N-3-苄基烯醇可用作细胞色素P450 2C19 (CYP2C19)抑制剂,以在处理混合物和单个基质的对比研究中,进行细胞色素P450(CYP)的有效抑制筛选。它也可用于比较研究,以探讨其在悬浮人肝细胞中作为CYP2C19的CYP和非CYP选择性抑制剂的潜力。

生化/生理作用

(+)-N-3-苄基-尼凡诺是一种强效选择性 CYP2C19 抑制剂。CYP2C19 具有较高的耐药频率;高度多态性。
(+)-N-3-苄基烯醇可用作细胞色素P450 2B6的抑制剂(CYP2B6)。

象形圖

Exclamation markEnvironment

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Acute 1 - Eye Irrit. 2

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

James P Driscoll et al.
Chemical research in toxicology, 20(10), 1488-1497 (2007-09-26)
The hypothesis that the psychological side effects associated with the anesthetic phencyclidine (PCP) may be caused by irreversible binding of PCP or its reactive metabolite(s) to critical macromolecules in the brain has resulted in numerous in vitro studies aimed at
Guru R Valicherla et al.
Xenobiotica; the fate of foreign compounds in biological systems, 49(12), 1396-1402 (2019-02-13)
1. A protocol has been developed and validated for the high-throughput screening of eight major human cytochrome P450 (CYP) isozymes inhibition (CYP 1A2, 2C9, 2C19, 2D6, 3A4, 2B6, 2C8 and 2E1) using an in vitro probe cocktail containing eight substrates
Marie-Lynn Cuypers et al.
Drug metabolism and disposition: the biological fate of chemicals, 48(11), 1121-1128 (2020-08-26)
Early assessment of metabolism pathways of new chemical entities guides the understanding of drug-drug interactions. Selective enzyme inhibitors are indispensable in CYP reaction phenotyping. The most commonly applied CYP2C19 inhibitor, omeprazole, lacks selectivity. Two promising alternatives, (+)-N-3-benzylnirvanol and (-)-N-3-benzylphenobarbital, are
Dustyn A Barnette et al.
Biochemical pharmacology, 170, 113661-113661 (2019-10-13)
Terbinafine N-dealkylation pathways result in formation of 6,6-dimethyl-2-hepten-4-ynal (TBF-A), a reactive allylic aldehyde, that may initiate idiosyncratic drug-induced liver toxicity. Previously, we reported on the importance of CYP2C19 and 3A4 as major contributors to TBF-A formation. In this study, we

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務